ALIVUS vs FDC: Stock Comparison
ALIVUS LIFE SCIENCES is the larger company by market capitalisation. ALIVUS LIFE SCIENCES shows a higher ROE, a higher ROCE and a higher net margin, while FDC shows a lower P/E, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ALIVUS leads 5; FDC leads 5 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ALIVUS | FDC |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | ALIVUS | FDC |
|---|---|---|
| Live Price | ₹1,427.2 | ₹378.8 |
| Day Change | 2.13% | 0.44% |
| Volume | 9.1 L | 1.27 L |
| 52-Week High | ₹1,493.8 | ₹473.6 |
| 52-Week Low | ₹819 | ₹312.95 |
| Distance from 52W High | -4.46% | -20.02% |
Valuation
| Metric | ALIVUS | FDC |
|---|---|---|
| Market Cap | ₹17,426 Cr | ₹6,171 Cr |
| P/E Ratio | 28.39x | 19.53x |
| P/B Ratio | 5.14x | 2.3x |
| EPS | ₹49.03 | ₹19.24 |
| Book Value | ₹271.02 | ₹163.75 |
| Dividend Yield | 0.36% | 2.66% |
Growth
| Metric | ALIVUS | FDC |
|---|---|---|
| Revenue Growth (TTM YoY) | 6.1% | 18.9% |
| EPS Growth (TTM YoY) | 14.5% | 166.8% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | ALIVUS | FDC |
|---|---|---|
| ROE | 16.94% | 11.47% |
| ROCE | 17.13% | 11.69% |
| Net Margin | 22.05% | 12.96% |
| Operating Margin | 29.65% | 18.03% |
| Debt to Equity | 0x | 0x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | ALIVUS | FDC |
|---|---|---|
| Promoter Holding | 74.85%▼ 0.02 pp | 69.66% |
| FII Holding | 5.93%▲ 0.39 pp | 1.58%▲ 0.18 pp |
| DII Holding | 7.03%▼ 0.15 pp | 6.59%▲ 0.28 pp |
| Public Holding | 12.19%▼ 0.22 pp | 22.17%▼ 0.46 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALIVUS LIFE SCIENCES and FDC.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.